INTERNATIONAL PATENT: BEIJING TONGREN HOSPITAL, CAPITAL MEDICAL UNIVERSITY, 首都医科大学附属北京同仁医院 FILES APPLICATION FOR "METHOD AND USE FOR PREDICTING OR EVALUATING EFFICACY OF OMALIZUMAB IN TREATMENT OF RECURRENT NASAL POLYPS BY USING TOPICAL IGE"

GENEVA, April 6 -- BEIJING TONGREN HOSPITAL, CAPITAL MEDICAL UNIVERSITY (No.1, DongJiaoMinXiangDongcheng District, Beijing 100730), 首都医科大学附属北京同仁医院 (中国北京市东城区东交民巷1号) filed a patent application (PCT/CN2024/133472) for "METHOD AND USE FOR PREDICTING OR EVALUATING EFFICACY OF OMALIZUMAB IN TREATMENT OF RECURRENT NASAL POLYPS BY USING TOPICAL IGE" on Nov 21, 2024. With publication no. WO/2025/067567, the details related to the patent application was published on Apr 03, 2025.

Notably, the patent application was submitted under the International Patent Classifi...